A 65-year-old kidney transplant recipient (in 1987) suffering from hypertension, hypothyroidism, aortic regurgitation, and benign prostatic hypertrophy, who was on cyclosporine, mycophenolate sodium, prednisone, levothyroxine, doxazosin, and furosemide, presented to the Emergency Room after three days of vomiting and diarrhea, without fever or abdominal pain. The patient had acute renal failure (creatinine 3.51 mg/dl), thus we decided to initiate empirical antibiotic therapy (ciprofloxacin) and fluid therapy after taking stool samples for culture according to our standard procedure (3). The culture was positive for Salmonella enterica, serogroup B1, with production of extended-spectrum beta-lactamase (Table I) . After the first few doses of intravenous antibiotic the diarrhea stopped and the patient recovered his renal function (creatinine 1.54 mg/dl), so he was sent home to complete treatment with antibiotics. The isolate was sent to the Spanish reference laboratory for Enterobacteriaceae, where it was confirmed and characterized. The presence of genes encoding the beta-lactamases TEM, CTX-M, and SHV were analyzed by PCR and sequencing on both strands (4). The isolate was confirmed as Salmonella enterica, subspecies enterica (I), serotype 4,5,12:i:-(monophasic Typhimurium), phage type 138, SHV-12 producer.
Discussion
Renal transplant patients receive immunosuppression for the prevention of graft rejection, which also predisposes patients to more infections and tumors. Infection is the second leading cause of death in kidney transplant recipients in our hospital ( 
